Particle.news

Download on the App Store

FDA Recalls Acne Treatments Over Benzene Contamination

Six benzoyl peroxide-based products pulled from shelves after testing revealed elevated levels of the cancer-linked chemical.

FILE - The Food and Drug Administration campus in Silver Spring, Md., is seen, Oct. 14, 2015. (AP Photo/Andrew Harnik, File)
People walk past a Walgreens Pharmacy and retail store in the Queens borough of New York City, NY, March 12, 2025.
Image
Image

Overview

  • The FDA has issued a retail-level recall for six acne treatment products containing benzoyl peroxide due to elevated benzene levels.
  • Products affected include La Roche-Posay Effaclar Duo, Proactiv Skin Smoothing Exfoliator, and Walgreens Acne Control Cleanser, among others.
  • Benzene, a known carcinogen, can cause leukemia and other cancers with prolonged exposure, though the FDA emphasizes the risk from these products is very low.
  • The recall follows FDA testing of 95 acne treatment products, with only six found to have elevated benzene levels, likely from manufacturing byproducts.
  • Consumers are not required to take action, but retailers are instructed to remove the affected products from shelves immediately.